JAKAFI

Product NDC
50881-020
11-digit product format
508810020
Labeler code
50881
Product ID
50881-020_baf91401-9bd0-4ce6-a5c4-7ca5c572f106
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ruxolitinib
Dosage form
TABLET
Route
ORAL
Labeler
Incyte Corporation
Application
NDA202192
Marketing category
NDA
Marketing start
2011-11-16
Substance
RUXOLITINIB
Active strength
20 mg/1
Pharmacologic classes
Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
JAKAFI
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
RUXOLITINIB20 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii82S8X8XX8H
Rxcui1193331, 1193337, 1193339, 1193341, 1193343, 1193345, 1193347, 1193349, 1193351, 1193353, 2743012, 2743016, 2743019, 2743022, 2743025, 2743028, 2743032, 2743035, 2743041, 2743044

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
54477ffc-bf5d-4583-bcf6-d041bdba36f1Product name120220316
95a946d8-a784-4eb7-bff4-2194e4331c6fProduct name120190828

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50881-020-60JAKAFI60 in 1 BOTTLE, PLASTICTABLET6040

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50881-020-60EA - Each50881-0209a257fa6-553e-47d0-948f-06aff337077012012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
RUXOLITINIBACTIVE INGREDIENT82S8X8XX8HJAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]13
RUXOLITINIBACTIVE MOIETY82S8X8XX8HJAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]13
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UJAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]13
HYDROXYPROPYL CELLULOSEINACTIVE INGREDIENTRFW2ET671PJAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]13
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XJAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]13
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30JAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]13
POVIDONEINACTIVE INGREDIENTFZ989GH94EJAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]13
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4JAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]13
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2JAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50881-020JAKAFI (RUXOLITINIB) TABLET [INCYTE CORPORATION]38Current NDC, Legacy NDC, 1 package rows20250120_f1c82580-87ae-11e0-bc84-0002a5d5c51b.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1193337Jakafi 10 MG Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193345Jakafi 15 MG Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193349Jakafi 20 MG Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193353Jakafi 25 MG Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193341Jakafi 5 MG Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743016Jakafi XR 11 MG 24HR Extended Release Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743022Jakafi XR 22 MG 24HR Extended Release Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743028Jakafi XR 33 MG 24HR Extended Release Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743035Jakafi XR 44 MG 24HR Extended Release Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743044Jakafi XR 55 MG 24HR Extended Release Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193331ruxolitinib 10 MG Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743012ruxolitinib 11 MG 24HR Extended Release Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193343ruxolitinib 15 MG Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193347ruxolitinib 20 MG Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743019ruxolitinib 22 MG 24HR Extended Release Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193351ruxolitinib 25 MG Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743025ruxolitinib 33 MG 24HR Extended Release Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743032ruxolitinib 44 MG 24HR Extended Release Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193339ruxolitinib 5 MG Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743041ruxolitinib 55 MG 24HR Extended Release Oral TabletPSNf1c82580-87ae-11e0-bc84-0002a5d5c51b40
274301624 HR ruxolitinib 11 MG Extended Release Oral Tablet [Jakafi]SBDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
274302224 HR ruxolitinib 22 MG Extended Release Oral Tablet [Jakafi]SBDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
274302824 HR ruxolitinib 33 MG Extended Release Oral Tablet [Jakafi]SBDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
274303524 HR ruxolitinib 44 MG Extended Release Oral Tablet [Jakafi]SBDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
274304424 HR ruxolitinib 55 MG Extended Release Oral Tablet [Jakafi]SBDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193337ruxolitinib 10 MG Oral Tablet [Jakafi]SBDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193345ruxolitinib 15 MG Oral Tablet [Jakafi]SBDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193349ruxolitinib 20 MG Oral Tablet [Jakafi]SBDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193353ruxolitinib 25 MG Oral Tablet [Jakafi]SBDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193341ruxolitinib 5 MG Oral Tablet [Jakafi]SBDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
274301224 HR ruxolitinib 11 MG Extended Release Oral TabletSCDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
274301924 HR ruxolitinib 22 MG Extended Release Oral TabletSCDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
274302524 HR ruxolitinib 33 MG Extended Release Oral TabletSCDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
274303224 HR ruxolitinib 44 MG Extended Release Oral TabletSCDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
274304124 HR ruxolitinib 55 MG Extended Release Oral TabletSCDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193331ruxolitinib 10 MG Oral TabletSCDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193343ruxolitinib 15 MG Oral TabletSCDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193347ruxolitinib 20 MG Oral TabletSCDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193351ruxolitinib 25 MG Oral TabletSCDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193339ruxolitinib 5 MG Oral TabletSCDf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193337Jakafi (as ruxolitinib phosphate) 10 MG Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193337Jakafi 10 MG Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193345Jakafi 15 MG Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193349Jakafi 20 MG Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193353Jakafi 25 MG Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193341Jakafi 5 MG Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743016Jakafi XR 11 MG 24 HR Extended Release Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743022Jakafi XR 22 MG 24 HR Extended Release Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743028Jakafi XR 33 MG 24 HR Extended Release Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743035Jakafi XR 44 MG 24 HR Extended Release Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743044Jakafi XR 55 MG 24 HR Extended Release Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193331ruxolitinib (as ruxolitinib phosphate) 10 MG Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193343ruxolitinib (as ruxolitinib phosphate) 15 MG Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193347ruxolitinib (as ruxolitinib phosphate) 20 MG Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193351ruxolitinib (as ruxolitinib phosphate) 25 MG Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
1193339ruxolitinib (as ruxolitinib phosphate) 5 MG Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743012ruxolitinib 11 MG 24 HR Extended Release Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743019ruxolitinib 22 MG 24 HR Extended Release Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743025ruxolitinib 33 MG 24 HR Extended Release Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743032ruxolitinib 44 MG 24 HR Extended Release Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40
2743041ruxolitinib 55 MG 24 HR Extended Release Oral TabletSYf1c82580-87ae-11e0-bc84-0002a5d5c51b40

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50881-020-605088100206060 TABLET in 1 BOTTLE, PLASTIC (50881-020-60) 60 tablet2011-11-160000-00-00NoNoCurrent